Patents by Inventor Joseph P. Balint

Joseph P. Balint has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
    Patent number: 11826417
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: November 28, 2023
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20230364218
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: July 28, 2023
    Publication date: November 16, 2023
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20230070595
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: November 14, 2022
    Publication date: March 9, 2023
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
    Patent number: 11529408
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: December 20, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20220370593
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: August 4, 2022
    Publication date: November 24, 2022
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
    Patent number: 11504423
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: November 22, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20220265809
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: April 27, 2022
    Publication date: August 25, 2022
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
    Patent number: 11389521
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: July 19, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Breast cancer vaccines and methods of use thereof
    Patent number: 11376316
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: July 5, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle
  • HPV vaccines and methods of use thereof
    Patent number: 11369673
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: June 28, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle
  • Sequential administration of a replication defective adenovirus vector in vaccination protocols
    Patent number: 11344613
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: September 18, 2012
    Date of Patent: May 31, 2022
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20200261565
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 20, 2020
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20170065706
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 9, 2017
    Inventors: Joseph P. BALINT, Frank R. JONES, Richard B. GAYLE
  • Sequential administration of a replication defective adenovirus vector in vaccination protocols
    Publication number: 20170065693
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 9, 2017
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle
  • SEQUENTIAL ADMINISTRATION OF A REPLICATION DEFECTIVE ADENOVIRUS VECTOR IN VACCINATION PROTOCOLS
    Publication number: 20130224144
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: September 18, 2012
    Publication date: August 29, 2013
    Applicant: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Sequential administration of a replication defective adenovirus vector in vaccination protocols
    Patent number: 8298549
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: January 4, 2010
    Date of Patent: October 30, 2012
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
    Publication number: 20100183673
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Application
    Filed: January 4, 2010
    Publication date: July 22, 2010
    Applicant: ETUBICS CORPORATION
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Method for treatment of rheumatoid arthritis
    Patent number: 5782792
    Abstract: Rheumatoid arthritis is treated by the extra corporeal removal of IgG and IgG-containing circulating immune complexes from the patient's blood. Removal is preferably accomplished by exposing the blood or blood plasma to a protein A immunoadsorbent which binds to IgG-containing immune complexes with high affinity.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: July 21, 1998
    Assignee: Cypress Bioscience, Inc.
    Inventors: Frank R. Jones, Harry W. Snyder, Jr., Joseph P. Balint, Jr.
  • Method for treating patients suffering from immune thrombocytopenic purpura
    Patent number: 5733254
    Abstract: Immune thrombocytopenic purpura is treated by removal of IgG and circulating immune complexes from the patient's blood. Removal is accomplished by exposing the blood or blood plasma to an immunoadsorbent capable of removing IgG and its complexes. The immunoadsorbent comprises a suitable solid phase coupled to a receptor capable of binding IgG and its complexes, such as protein A. The IgG and its complexes are then removed by the extracorporeal exposure of the patient's blood to the immunoadsorbent, either in a continuous or discontinuous process. In the continuous process, the blood is removed in a steady flow from the patient, separated into its plasma and cellular components, the plasma treated, and the combined cellular components and treated plasma reinfused to the patient.
    Type: Grant
    Filed: May 1, 1995
    Date of Patent: March 31, 1998
    Assignee: Cypress Bioscience, Inc.
    Inventors: Frank R. Jones, Joseph P. Balint, Jr., Harry W. Snyder
  • Purification of protein a by affinity chromatography followed by anion exchange
    Patent number: 5075423
    Abstract: Affinity-purified protein A preparations are contacted with a suitable anionic exchange material in order to remove trace contamination. Staphylococcal enterotoxin B (SEB) and other proteinaceous contaminants are removed by passing such affinity-purified protein A preparations through a DEAE-cellulose column and thereafter selectively eluting the protein A to separate the contaminants. Very high purity protein A composition are thus obtained, typically having a contaminant concentration of about 5 weight % or below, with below about 0.001 weight % SEB.
    Type: Grant
    Filed: January 24, 1990
    Date of Patent: December 24, 1991
    Assignee: Imre Corporation
    Inventor: Joseph P. Balint, Jr.